India is at a crossroads. It can follow the route it has taken in software engineering, or it can travel the opposite route with idiosyncratic rules that limit growth and innovation.

India is at a crossroads: it can protectintellectual property orlimit growth and innovation.

The drug regulatory system in India needs to be improved for domestic consumption and because India is an increasingly important exporter of drugs for both developed and developing countries.